Ejorango, Julieto M.
HRN: 231-23-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/20/2022
04/27/2022
IV
600mg
Q8H
Infected Wound Right Leg
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes